EmitBio

Closed portfolio snapshot

According to ClinicalTrials.gov-derived indexes, EmitBio sits in the upper quartile of US sponsors by registered trial count (#2,411 of 15,742 sponsors by registered trial count).

5 total trials none currently recruiting 4 completed upper quartile by trial count

EmitBio: 5 sponsored US clinical trials, none currently recruiting.

EmitBio sponsors 5 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 4 completed. The most-studied condition in this pipeline is COVID-19, with 1 trials.

Upper-quartile sponsor footprint

EmitBio sits in the upper quartile of the sponsor corpus (#2,411 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.

Indexed trials (enrollment closed)

5 total, page 1 of 1

TERMINATED NA

Pilot Randomized Study of RD-X19 Tx Device in Subjects With PCC (Long Covid) in the Outpatient Setting

NCT06113679
COMPLETED NA

Evaluation of the RD-X19 Treatment Device in Individuals With Mild COVID-19

NCT05817045
COMPLETED NA

Evaluation of the RD-X19 Treatment Device in Individuals With Mild to Moderate COVID-19

NCT04966013
COMPLETED NA

Phase I/II Safety, Dose Finding & Antiviral Activity of RD-X19 in Mild/Moderate Outpatient COVID-19

NCT04662671
COMPLETED NA

Acute Safety and Acceptability Study of Experimental Device RD19 for Protection From Human Respiratory Disease Pathogens

NCT04557826

Therapeutic Areas

COVID-19 1

How the EmitBio archive is shaped

5 indexed studies, none listed as recruiting (0% open); 4 completed (80%).

Phase labels are sparse on this sponsor index, so phase mix is not charted here.

Top condition: COVID-19 (1 trial), 0 others listed.

How to read a closed sponsor archive

When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.

EmitBio: archived-pipeline peers nationwide

Peers matched on 5 indexed studies with no current recruiting: volume and archive shape, not condition overlap.

EmitBio sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 051015 0%5%10%15%20%25% Total trials Recruiting share EmitBio4YouandMeAbbott Rapid DxAccess Business GroupAcera Surgical10xBio22nd Century Group23andMe3-C Institute for Social Development
EmitBio sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

EmitBio sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 5 archived trials

Sponsors with similar archive density (± trial count)

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this EmitBio page

5 registered trials is a research-attention snapshot, not an endorsement of EmitBio or any single study.

  • None of EmitBio's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
  • COVID-19 is the condition EmitBio studies most, compare against other sponsors active in the same condition before evaluating a specific study. See COVID-19 trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

EmitBio pipeline card: 5 registered trials from official public datasets.Report a data error.